{"organizations": [], "uuid": "753169858834b9f64197bba585293db50efbd9fc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/02/the-associated-press-conatus-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Conatus: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-03T02:21:00.000+03:00", "replies_count": 0, "uuid": "753169858834b9f64197bba585293db50efbd9fc"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/02/the-associated-press-conatus-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Conatus: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "san diego", "sentiment": "none"}], "organizations": [{"name": "conatus pharmaceuticals inc.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "SAN DIEGO (AP) _ Conatus Pharmaceuticals Inc. (CNAT) on Wednesday reported a loss of $5 million in its first quarter.\nThe San Diego-based company said it had a loss of 17 cents per share.\nThe results matched Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 17 cents per share.\nThe biotechnology company posted revenue of $9.7 million in the period, beating Street forecasts. Six analysts surveyed by Zacks expected $8.9 million.\nIn the final minutes of trading on Wednesday, the company's shares hit $3.68. A year ago, they were trading at $8.39.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on CNAT at https://www.zacks.com/ap/CNAT", "external_links": ["https://www.zacks.com/ap/CNAT", "http://automatedinsights.com/ap"], "published": "2018-05-03T02:21:00.000+03:00", "crawled": "2018-05-03T09:25:14.003+03:00", "highlightTitle": ""}